ID

25854

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Montral Cognitive Assessment (MoCA)

Palabras clave

  1. 21/9/17 21/9/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

21 de septiembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

MoCA General information
Descripción

MoCA General information

1. Date of visit/assessment
Descripción

Date of visit/assessment

Tipo de datos

date

Informed consent
Descripción

Informed consent

Tipo de datos

text

MoCA Eligibility Question
Descripción

MoCA Eligibility Question

1. Did subject meet all MoCA eligibility criteria?
Descripción

MoCA eligibility criteria met

Tipo de datos

text

[I51] 1. Availability of an approved translation
Descripción

Inclusion criterion

Tipo de datos

boolean

[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
Descripción

Inclusion criterion

Tipo de datos

boolean

[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
Descripción

Exclusion criterion

Tipo de datos

boolean

Montreal Cognitive Assessment
Descripción

Montreal Cognitive Assessment

MoCA Status
Descripción

MoCA Status

Tipo de datos

text

Montreal Cognitive Assessment (MoCA)
Descripción

Montreal Cognitive Assessment (MoCA)

Tipo de datos

text

Similar models

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
MoCA General information
Date of visit/assessment
Item
1. Date of visit/assessment
date
Informed consent
Item
Informed consent
text
Item Group
MoCA Eligibility Question
Item
1. Did subject meet all MoCA eligibility criteria?
text
Code List
1. Did subject meet all MoCA eligibility criteria?
CL Item
Yes (Y)
CL Item
No, please select all boxes corresponding to the criteria that were not met (N)
Availability of an approved translation
Item
[I51] 1. Availability of an approved translation
boolean
informed consent
Item
[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
boolean
physical limitation
Item
[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
boolean
Item Group
Montreal Cognitive Assessment
MoCA Status
Item
MoCA Status
text
Montreal Cognitive Assessment (MoCA)
Item
Montreal Cognitive Assessment (MoCA)
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial